home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Marrone Bio Innovations announces plans for CFO succession - President and CFO James Boyd to retire from the company; search process for new CFO underway


Davis, California, USA
September 22, 2020

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that company President and Chief Financial Officer James Boyd will retire from his positions.

A national search process for the new Chief Financial Officer is underway, and Mr. Boyd will continue as President and CFO during the search process.

“Jim has been a key member of the senior management team and a highly-regarded leader for the company over the last seven years” said Chief Executive Officer Kevin Helash. “He has helped guide the company through its successful transition as a market leader in the agricultural biologicals space. On behalf of myself, the board of directors and the entire team at Marrone Bio Innovations, we want to thank Jim for his numerous contributions to the strength of the company and wish him the very best in his retirement.”

“The search for a new CFO is underway, and we are looking for an exceptional individual to help lead the company during its next phase of accelerated growth while ensuring we are brilliant at the basics that drive operational and financial excellence,” added Helash.  “We have a solid financial team in place and expect the new CFO to be able to make a rapid transition and add immediate value.”

“I am proud to have helped build the company into a world-class organization with an unmatched product portfolio in sustainable biological products.  Given our recent revenue growth and margin expansion, I am confident the company is poised to deliver meaningful shareholder value.  I look forward to working with our finance team as we make this transition and ensure the company’s continuing success,” said Boyd.

 



More news from: Marrone Bio Innovations


Website: http://marronebioinnovations.com/

Published: September 22, 2020

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 

 


Copyright @ 1992-2024 SeedQuest - All rights reserved